
Journal of Organometallic Chemistry p. 19 - 30 (1996)
Update date:2022-09-26
Topics:
Fierro, Ricardo
Bitterwolf, Thomas E.
Rheingold, Arnold L.
Yap, Glenn P. A.
Liable-Sands, Louise M.
A series of new ring-coupled bimetallic complexes M2(CO)6[η5,η5-C5H4-C(CH3)2-C5H4], where M = Cr, Mo, W, was synthesized by reaction of the dianion of the ligand 2,2-bis(cyclopentadienyl)propane and M(CO)3(CH3CN)3, M = Cr, Mo, W. Oxidation with acetic acid-Fe(III) produced the bimetallic complexes in moderate yields. Using the same strategy, reactions of Mo(CO)3(CH3CN)3 with the dianion of 2-cyclopentadienyl-2-indenylpropane produced only the dimer [Mo(CO)3[η5-C5H4-C(CH3)2-C9H7]2 in which the indenyl ring was unmetallated. Subsequent detailed studies revealed that the desired dimetalloanion was initially formed, but that the indenyl bound metal was lost upon protonation. Evidence for the mechanism of this demetallation process is presented. The dimetalloanion could be intercepted by methyl iodide to form [Mo(CO)3CH3]2[η5,η5-C5H4-C(CH3)2-(C9H6)]. Synthesis of Mo2(CO)6[η5,η5-C5H4-C(CH3)2-(3-RC9H5)], where R = H, CH3, was achieved by aprotic oxidation of the intermediate dimetalloanion by ferricinium tetraphenylborate. The molecular structures of two compounds are reported: Mo2(CO)6[η5,η5-C5H4-C(CH3)2-(3-CH3C9H5)]: triclinic, P1, a = 8.777(3) A, b = 9.428(4) A, c = 14.915(4) A, α = 91.42(3)°, β = 102.04(3)°, γ=114.69(3)°, V-1087.9(8) A3, Z = 2, R(F) = 3.03%.[Mo(CO)3CH3]2[η5,η5-C5H4-C(CH3)2-(C9H6)]: triclinic, P1, a = 8.298(6) A, b= 11.662(6) A, c= 13.241(8) A, a = 100.28(1)°, β = 93.02(l)°, γ - 99.72(1)°, V-1238(1) A3, Z=2, R(F) = 3.99.%.
Jinan Jianfeng Chemical Co., Ltd
Contact:0086-531-88110457
Address:sales01(-a-t-)pharmachemm{dot}c+o+m
Contact:17316303296
Address:240 Amboy Ave
Contact:86-898-65311214
Address:Room 102, BLDG. 68 Jiangnan City, No. 66 Heping Road,Haikou, Hainan, China
Beyond Pharmaceutical Co., Ltd
Contact:+86-571-8195-3185
Address:No. 13-1, Liansheng Road, Yuhang District
Taizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
Doi:10.1016/S0022-328X(96)06382-6
(1996)Doi:10.1002/jhet.5570330674
(1996)Doi:10.1002/jhet.5570330606
(1996)Doi:10.1021/ac00254a034
(1983)Doi:10.1016/S0040-4020(02)00096-0
(2002)Doi:10.1021/ja963036t
(1997)